Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: LENSAR Inc., 3 years.
LENSAR Inc.
Director
Ocular Therapeutix Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
LENSAR Inc. August 4, 202687.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | Ocular Therapeutix Inc. | Grant or award | +14,000 | — | — |
| Jun 3, 2026 | LENSAR Inc. | Grant or award | +17,421 | — | — |
| Feb 20, 2026 | Ocular Therapeutix Inc. | Open-market purchase | +60,229 | $7.66 | $461,354 |
| Jun 11, 2025 | Ocular Therapeutix Inc. | Grant or award | +14,000 | — | — |
| May 23, 2025 | LENSAR Inc. | Grant or award | +7,374 | — | — |
| May 8, 2025 | Ocular Therapeutix Inc. | Open-market purchase | +10,000 | $6.96 | $69,600 |
| Jul 24, 2024 | Ocular Therapeutix Inc. | Grant or award | +12,000 | — | — |
| May 7, 2024 | LENSAR Inc. | Grant or award | +22,000 | — | — |
| Feb 27, 2024 | Ocular Therapeutix Inc. | Option exercise | +18,939 | $8.80 | $166,663 |
| Feb 27, 2024 | Ocular Therapeutix Inc. | Option exercise | +11,363 | $8.80 | $99,994 |
| Jun 14, 2023 | Ocular Therapeutix Inc. | Grant or award | +12,000 | — | — |
| May 25, 2023 | LENSAR Inc. | Grant or award | +9,288 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.